We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Slower Rewarming Benefits Bypass Patients

By HospiMedica staff writers
Posted on 18 May 2004
A study has confirmed that spending an extra 10-15 minutes slowly rewarming patients after cardiac bypass surgery reduces the likelihood of cognitive decline after surgery.

Rapid rewarming can lead to a spike in brain temperature, according to the researchers. More...
By allowing patients to return to normal temperatures at a slower rate, doctors can also reduce the possibility of temperatures spiking high enough to harm the brain. Over a seven-year period, the maximum temperatures of patients being rewarmed after undergoing coronary artery bypass surgery at Duke University Hospital (Durham, NC, USA) dropped an average of more than 1.5oC.

However, the researchers say that many surgical teams are unaware of the importance of temperature in affecting the outcomes of bypass surgery. "The reasons why slower rewarming has not become more widespread are numerous, ranging from the inherent resistance to changing long-standing medical practices, to not wanting to spend the additional time in the operating room,” said Hilary Grocott, M.D., who presented the results of the Duke study at the annual meeting of the Society of Cardiovascular Anesthesiologists in Honolulu (HI, USA) in April 2004.

In earlier studies, Duke researchers found that patients who were allowed an additional 10-12 minutes to return to normal body temperature scored almost one-third better on standard tests of cognition six weeks after surgery. Specifically, they found that patients who were returned to normal temperature an average of 0.49oC per minute fared better than those rewarmed at the typical rate of 0.56oC per minute.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.